Periodontal Disease Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Periodontal Disease pipeline constitutes key companies continuously working towards developing Periodontal Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

Periodontal Disease Overview
Periodontal diseases are mainly the result of infections and inflammation of the gums and bone that surround and support the teeth. In its early stage, called gingivitis, the gums can become swollen and red, and they may bleed. In its more serious form, called periodontitis, the gums can pull away from the tooth, bone can be lost, and the teeth may loosen or even fall out. Periodontal disease is mostly seen in adults. Periodontal disease and tooth decay are the two biggest threats to dental health.

"Periodontal Disease Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Periodontal Disease Market.

The Periodontal Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Periodontal Disease Pipeline Report: https://www.delveinsight.com/report-store/periodontal-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Periodontal Disease treatment therapies with a considerable amount of success over the years. Periodontal Disease Key players such as - Vaxcyte, AngioLab, Inc., Cortexyme, Noveome Biotherapeutics, Amyndas Pharmaceuticals, D and D Pharmatech, and others, are developing therapies for the Periodontal Disease treatment
• Periodontal Disease Emerging therapies such as - VAX PG, AL102-PDT, COR-588, ST266, AMY-101, P4M01, and others are expected to have a significant impact on the Periodontal Disease market in the coming years.
• In March 2021, Amyndas Pharmaceuticals announced positive top-line Phase II results from its randomized, placebo controlled clinical trial evaluating AMY-101 in 39 patients with periodontal inflammation and gingivitis
• On July 22, 2019, Amyndas Pharmaceuticals initiated a Phase II a clinical trial to assess the safety and efficacy of C3 inhibitor AMY-101, in adults with Gingivitis. The phase 2 trial was a 3-month randomized, double-blind, split-mouth study in adults with gingivitis and chronic periodontal inflammation

Periodontal Disease Pipeline Therapeutics Assessment
• Periodontal Disease Assessment by Product Type
• Periodontal Disease By Stage and Product Type
• Periodontal Disease Assessment by Route of Administration
• Periodontal Disease By Stage and Route of Administration
• Periodontal Disease Assessment by Molecule Type
• Periodontal Disease by Stage and Molecule Type

DelveInsight's Periodontal Disease Report covers around products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Some of the key companies in the Periodontal Disease Therapeutics Market include:
Key companies developing therapies for Periodontal Disease are - Amyndas Pharmaceuticals, 3M, AMD Lasers, Inc., ASA Dental S.p.A, Biolase, Inc., Carl Martin GmbH, Danaher, Dentsply Sirona, Deppeler SA, Karl Schumacher, Medtronic, Novartis AG, Pfizer, Inc., Planmeca Oy, Steris-Hu-Friedy, and Straumann AG., and others.

Emerging Periodontal Disease Drugs Under Different Phases of Clinical Development Include:
• VAX PG: Vaxcyte
• AL102-PDT: AngioLab, Inc.
• COR-588: Cortexyme
• ST266: Noveome Biotherapeutics
• AMY-101: Amyndas Pharmaceuticals
• P4M01: D and D Pharmatech

Get a Free Sample PDF Report to know more about Periodontal Disease Pipeline Therapeutic Assessment- https://www.delveinsight.com/sample-request/periodontal-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Periodontal Disease Pipeline Analysis:
The Periodontal Disease pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Periodontal Disease with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Periodontal Disease Treatment.
• Periodontal Disease key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Periodontal Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Periodontal Disease market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Further Periodontal Disease product details are provided in the report. Download the Periodontal Disease pipeline report to learn more about the emerging Periodontal Disease therapies at:
https://www.delveinsight.com/sample-request/periodontal-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Periodontal Disease Pipeline Market Drivers
• Growing awareness about oral hygiene
• Rising geriatric population across the world

Periodontal Disease Pipeline Market Barriers
• Growing awareness about oral hygiene
• Rising geriatric population across the world

Scope of Periodontal Disease Pipeline Drug Insight
• Coverage: Global
• Key Periodontal Disease Companies: Vaxcyte, AngioLab, Inc., Cortexyme, Noveome Biotherapeutics, Amyndas Pharmaceuticals, D and D Pharmatech, and others
• Key Periodontal Disease Therapies: VAX PG, AL102-PDT, COR-588, ST266, AMY-101, P4M01, and others
• Periodontal Disease Therapeutic Assessment: Periodontal Disease current marketed and Periodontal Disease emerging therapies
• Periodontal Disease Market Dynamics: Periodontal Disease market drivers and Periodontal Disease market barriers

Request for Sample PDF Report for Periodontal Disease Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/periodontal-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Periodontal Disease Report Introduction
2 Periodontal Disease Executive Summary
3 Periodontal Disease Overview
4 Periodontal Disease- Analytical Perspective In-depth Commercial Assessment
5 Periodontal Disease Pipeline Therapeutics
6 Periodontal Disease Late Stage Products (Phase II/III)
7 Periodontal Disease Mid Stage Products (Phase II)
8 Periodontal Disease Early Stage Products (Phase I)
9 Periodontal Disease Preclinical Stage Products
10 Periodontal Disease Therapeutics Assessment
11 Periodontal Disease Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Periodontal Disease Key Companies
14 Periodontal Disease Key Products
15 Periodontal Disease Unmet Needs
16 Periodontal Disease Market Drivers and Barriers
17 Periodontal Disease Future Perspectives and Conclusion
18 Periodontal Disease Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report to know more about Periodontal Disease drugs and therapies- https://www.delveinsight.com/sample-request/periodontal-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Related Reports:

Periodontal Disease Market https://www.delveinsight.com/report-store/periodontal-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Periodontal Disease-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Periodontal Disease Epidemiology https://www.delveinsight.com/report-store/periodontal-disease-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Periodontal Disease Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Scedosporium Infection Market https://www.delveinsight.com/report-store/scedosporium-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2027 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2027 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Bladder Scanners Market https://www.delveinsight.com/report-store/bladder-scanners-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Contact Us:

Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.